Trogocytosis of CD80 and CD86 by induced regulatory T cells

被引:0
|
作者
Peng Gu
Julia Fang Gao
Cheryl A D'Souza
Aleksandra Kowalczyk
Kuang-Yen Chou
Li Zhang
机构
[1] University of Toronto Transplant Institute,Department of Immunology
[2] Toronto General Research Institute,undefined
[3] University Health Network,undefined
[4] Shanghai Institute of Immunology,undefined
[5] Shanghai Jiaotong University School of Medicine,undefined
[6] University of Toronto,undefined
来源
关键词
CD80; CD86; CTLA-4; iTregs; trogocytosis;
D O I
暂无
中图分类号
学科分类号
摘要
Trogocytosis is a process which involves the transfer of membrane fragments and cell surface proteins between cells. Various types of T cells have been shown to be able to acquire membrane-bound proteins from antigen-presenting cells and their functions can be modulated following trogocytosis. However, it is not known whether induced regulatory T cells (iTregs) can undergo trogocytosis, and if so, what the functional consequences of this process might entail. In this study, we show that iTregs can be generated from CD80−/−CD86−/− double knockout (DKO) mice. Using flow cytometry and confocal fluorescence microscopy, we demonstrate that iTregs generated from DKO mice are able to acquire both CD80 and CD86 from mature dendritic cells (mDCs) and that the acquisition of CD86 occurs to a higher extent than that of CD80. Furthermore, we found that after co-incubation with iTregs, dendritic cells (DCs) downregulate their surface expression of CD80 and CD86. The trogocytosis of both CD80 and CD86 occurs in a cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), CD28 and programmed death ligand-1 (PDL1)-independent manner. Importantly, we showed that iTregs that acquired CD86 from mDCs expressed higher activation markers and their ability to suppress naive CD4+ T-cell proliferation was enhanced, compared to iTregs that did not acquire CD86. These data demonstrate, for the first time, that iTregs can acquire CD80 and CD86 from mDCs, and the acquisition of CD86 may enhance their suppressive function. These findings provide novel understanding of the interaction between iTregs and DCs, suggesting that trogocytosis may play a significant role in iTreg-mediated immune suppression.
引用
收藏
页码:136 / 146
页数:10
相关论文
共 50 条
  • [31] CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86
    Ciriana Orabona
    Ursula Grohmann
    Maria Laura Belladonna
    Francesca Fallarino
    Carmine Vacca
    Roberta Bianchi
    Silvia Bozza
    Claudia Volpi
    Benoît L Salomon
    Maria Cristina Fioretti
    Luigina Romani
    Paolo Puccetti
    Nature Immunology, 2004, 5 : 1134 - 1142
  • [32] Identification of another primordial CD80/86 molecule in rainbow trout: Insights into the origin and evolution of CD80 and CD86 in vertebrates
    Zhang, Xu-Jie
    Zhang, Xiang-Yang
    Wang, Peng
    Zhang, Yong-An
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2018, 89 : 73 - 82
  • [33] Simultaneous gene silencing of pig CD80 and CD86 but not single CD80, CD86 or CD40 by RNAI prevents costimulation of human anti-pig T cell responses.
    Kim, JY
    Kim, D
    Choi, I
    Yang, JS
    Lee, DS
    Lee, JR
    Miyagawa, S
    Matsunami, K
    Hwang, WS
    Kim, S
    Lee, JS
    Ahn, C
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 244 - 244
  • [34] CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86
    Orabona, C
    Grohmann, U
    Belladonna, ML
    Fallarino, F
    Vacca, C
    Bianchi, R
    Bozza, S
    Volpi, C
    Salomon, BT
    Fioretti, MC
    Romani, L
    Puccetti, P
    NATURE IMMUNOLOGY, 2004, 5 (11) : 1134 - 1142
  • [35] Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
    Trzupek, Dominik
    Dunstan, Melanie
    Cutler, Antony J.
    Lee, Mercede
    Godfrey, Leila
    Jarvis, Lorna
    Rainbow, Daniel B.
    Aschenbrenner, Dominik
    Jones, Joanne L.
    Uhlig, Holm H.
    Wicker, Linda S.
    Todd, John A.
    Ferreira, Ricardo C.
    GENOME MEDICINE, 2020, 12 (01)
  • [36] Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
    Dominik Trzupek
    Melanie Dunstan
    Antony J. Cutler
    Mercede Lee
    Leila Godfrey
    Lorna Jarvis
    Daniel B. Rainbow
    Dominik Aschenbrenner
    Joanne L. Jones
    Holm H. Uhlig
    Linda S. Wicker
    John A. Todd
    Ricardo C. Ferreira
    Genome Medicine, 12
  • [37] Interactions of CD80 and CD86 with CD28 and CTLA4
    Ellis, JH
    Burden, MN
    Vinogradov, DV
    Linge, C
    Crowe, JS
    JOURNAL OF IMMUNOLOGY, 1996, 156 (08): : 2700 - 2709
  • [38] The relationship of VIP in gastric cancer with CD80, CD86 in the inflammatory cells of gastric cancer
    Li Yuanyuan
    Gan Bo
    Yang Leying
    Li Guohua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 817 - 818
  • [39] Immunomodulatory molecules in renal cell cancer: CD80 and CD86 are expressed on tumor cells
    Floercken, Anne
    Johannsen, Manfred
    Nguyen-Hoai, Tam
    Gerhardt, Anne
    Miller, Kurt
    Doerken, Bernd
    Pezzutto, Antonio
    Westermann, Joerg
    Joehrens, Korinna
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 1443 - 1454
  • [40] The expression of CD80 and or CD86 on target cells is not associated with the intensity of cytotoxicity by human NK cells
    Osman, Y
    Takahashi, M
    Toba, K
    Zheng, ZY
    Liu, AC
    Furukawa, T
    Aoki, S
    Watanabe, H
    Kawamura, T
    Abo, T
    Aizawa, Y
    Koike, T
    BIOMEDICAL RESEARCH-TOKYO, 1998, 19 (06): : 381 - 389